实用肿瘤学杂志 ›› 2013, Vol. 27 ›› Issue (5): 457-459.doi: 10.3969/j.issn.1002-3070.2013.05.018

• 综述 • 上一篇    下一篇

Mfn2/HSG与恶性肿瘤

罗卫综述,赵晓平审校   

  1. 陕西中医学院附属医院神经外科(咸阳 712000)
  • 收稿日期:2013-05-26 出版日期:2013-10-28 发布日期:2013-10-15
  • 通讯作者: 罗卫,E-mail:longshangby@163.com
  • 作者简介:罗卫,男,(1974-),硕士,主治医师,从事脑肿瘤及脑血管病研究
  • 基金资助:
    咸阳市科学技术局资助项目(2012k16-02)

Mfn2/HSG and malignant tumors

LUO Wei,ZHAO Xiaoping   

  1. Department of Neurosurgery,Affiliated Hospital of Shanxi TCM College,Xianyang 712000,China
  • Received:2013-05-26 Online:2013-10-28 Published:2013-10-15

摘要: 线粒体融合蛋白-2基因(Mitofusin-2,Mfn2)是一个新的细胞增殖抑制剂,可以促进细胞凋亡、抑制肿瘤细胞增生。本文对Mfn2的生物学特性及其与恶性肿瘤之间的关系做一综述,为恶性肿瘤的临床诊治提供一个新的参考指标。

Abstract: Mitofusin-2(Mfn2)is a novel suppressor of cell proliferation,which could promote apoptosis and inhibit proliferation of tumor cells.In this paper,we review the biological characteristics of Mfn2 and its relationship with malignant tumors,and further to provide a new reference index for clinical treatment of cancer.

中图分类号: